Sort & Filter
1 result found
PXT3003 in Charcot-Marie-Tooth Type 1A
The purpose of this study is to evaluate the effectiveness of an investigational drug called PXT3003 for the treatment of Charcot-Marie-Tooth type 1A (CMT1A disease). Researchers will compare PXT3003 to placebo (inactive substance) on the ...